PODCASTS
Drug prices are a thorn in the side of U.S. health care, rising much faster than the medical cost trend. What's driving these costs and what can actuaries do to apply their expertise in finding a solution?
Nate Worrell is breaking new ground exploring the intersection of actuarial science and good nutrition, taking fresh new view of food as an influence on health outcomes.
What's the best way for actuaries to sharpen their skills in the changing business world? Geisinger Chief Actuary Kurt Wrobel advises keeping a close eye on the horizon in order to identify the skill set we'll need in the future.
As the insurance market has changed, the consumer and carrier view of Supplemental Benefits also has changed, dramatically. Opportunities for actuaries are abundant.
Health reimbursement arrangements (HRAs) are becoming increasingly common as more employers are seeking an alternative to traditional health benefits. How do they compare to health insurance under the Affordable Care Act? What are the advantages and disadvantages? As an issue centered on consumer value, how do actuaries define and measure the concept?
Blockchain technology can have a significant role in the future delivery of health care. But experts say in order for it to drive innovation, it must operate in an ecosystem of data security, validity and seamless access.
The Society of Actuaries has a robust and extensive research program. Here is an overview of how SOA research is funded and a look at some of the recent and upcoming research projects.
Pharmacy rebates impact the healthcare market in several ways. Lawmakers and regulators are considering several potential changes regarding the transparency of these rebates. Here's what actuaries need to know when pricing or reserving health products.
Listen as Marty Makary, M.D. discuss his new book, "The Price We Pay: What Broke America's Health Care - and How to Fix it."